Brian Slomovitz, Director of Gynecologic Oncology at Mount Sinai Medical Center, shared on LinkedIn:
“Just published online…
Low grade serous ovarian cancers (LGSOC) are a rare subtype of ovarian cancer. They affect younger women and effective treatment options are limited. We held our 3rd LGSOC Consensus Conference bringing together key opinion leaders in the field to help learn more about the disease and to use this as a way to come up with better treatment options. This publication is the report from this conference.
It is a great privilege for me to co-lead this conference with David Gershenson, Rachel Grisham, both world renowned experts in the field.”
Title: Low-grade serous ovarian cancer: 2026 expert consensus report
Authors: Rachel N. Grisham, Brian Slomovitz, Vivek Podder, Charlotte Sun, Nicole Andrews, Beryl Manning-Geist, Russell Vang, Lauren P. Cobb, Susana Banerjee, Charlie Gourley, Allireza Alloo, Amanda N. Fader, Jubilee Brown, Stéphanie Gaillard, Isabelle Ray-Coquard, David M. O’Malley, Heather E. Cunliffe, Shannon N. Westin, Dimitrios Nasioudis, Thomas J. Herzog, Kathleen N. Moore, Robert L. Coleman, Mark S. Carey, Anna DeFazio, Fiona Simpkins, Robert L. Hollis, Kwong-Kwok Wong, Dane Cheasley, Anil K. Sood, Jane Ludemann, Rosemary L. Balleine, Elsa Larsen, Alicia Didsbury, Emily Campbell, Michelle Flint, Jeffrey Girshman, Anais Malpica, Kathleen I. Pishas, David M. Gershenson
Read the Full Article on Gynecologic Oncology
You can also read: OCRF and News Corp Australia Launch “Over It” Campaign to Close the Ovarian Cancer Survival Gap
